Efficacy and Safety of First-Line Cytokines versus Sunitinib and Second-Line Axitinib for Patients with Metastatic Renal Cell Carcinoma (ESCAPE Study): A Phase III, Randomized, Sequential Open-Label Study.

Item request has been placed!

Item request cannot be made.

Processing Request

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

المؤلفون: Kadono, Yoshifumi¹ (AUTHOR) ; Konaka, Hiroyuki^1,2 (AUTHOR); Nohara, Takahiro¹ (AUTHOR); Izumi, Kouji¹ (AUTHOR); Anai, Satoshi³ (AUTHOR); Fujimoto, Kiyohide³ (AUTHOR); Koguchi, Tomoyuki⁴ (AUTHOR); Ishibashi, Kei^4,5 (AUTHOR); Kawai, Noriyasu⁶ (AUTHOR); Nakane, Keita⁷ (AUTHOR); Iba, Akinori⁸ (AUTHOR); Masumori, Naoya⁹ (AUTHOR); Takahara, Shizuko¹⁰ (AUTHOR); Mizokami, Atsushi¹ (AUTHOR)
المصدر:
Cancers. May2023, Vol. 15 Issue 10, p2745. 15p.